ACARBOSE TABLETS DIN 02493780
Health Canada record
| Active ingredient(s) | ACARBOSE 50 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A10BF01 ACARBOSE |
| Original market date | 28-May-2020 |
| Current status date | 28-May-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Strides Pharma Canada Inc. — licence 3-002485, currently licensed, last inspection rating C (2026-03-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ACARBOSE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02494078 | MAR-ACARBOSE | MARCAN PHARMACEUTICALS INC | Tablet | ACARBOSE 50 MG | Marketed |
| 02494086 | MAR-ACARBOSE | MARCAN PHARMACEUTICALS INC | Tablet | ACARBOSE 100 MG | Marketed |
| 02493799 | ACARBOSE TABLETS | STRIDES PHARMA CANADA INC | Tablet | ACARBOSE 100 MG | Dormant |
| 02190885 | GLUCOBAY | BAYER INC | Tablet | ACARBOSE 50 MG | Cancelled Post Market |
| 02190893 | GLUCOBAY | BAYER INC | Tablet | ACARBOSE 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 33461 | 2024-06-18 | Abbreviated New Drug Submission (ANDS) | Administrative: Change in Product Ownership |
| 22885 | 2019-11-08 | Abbreviated New Drug Submission (ANDS) |
International API supply for ACARBOSE
6 valid EDQM Certificates of Suitability from 6 holders. 7 active FDA Drug Master Files.
Request a quote for ACARBOSE TABLETS